Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Granulomatosis with Polyangiitis

• A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
• PR3-AAV Resilient Remission or PRRR
• Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers
• Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
• Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
• Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
• Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
• Hydroxychloroquine in ANCA Vasculitis Evaluation
• Rituximab and Belimumab Combination Therapy in PR3 Vasculitis
• Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
• TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
• Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
• Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
• Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
• Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
• Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.
• Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
• Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
• Rituximab in Eosinophilic Granulomatosis With Polyangiitis
• Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
• Low-dose Glucocorticoid Vasculitis Induction Study
• Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
• A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
• Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
• A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
• Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
• The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
• The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
• A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
• Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
• Rituximab Vasculitis Maintenance Study
• Belimumab in Remission of VASculitis
• An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
• BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis
• Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis
• Plasma Exchange for Renal Vasculitis
• Alemtuzumab for ANCA Associated Refractory Vasculitis
• Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
• Anti-Cytokine Therapy for Vasculitis
• Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
• Efficacy Study of Two Treatments in the Remission of Vasculitis
• Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
• Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
• Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
• Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
• WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
• Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
• RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
• Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
• Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
• Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
• An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
• Daclizumab to Treat Wegener's Granulomatosis
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
• Etanercept for Wegener's Granulomatosis
• Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
• Etanercept to Treat Wegener's Granulomatosis
• Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
• Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
• Steroids and Methotrexate to Treat Systemic Vasculitis
• Treatment of Wegener's Granulomatosis With Cyclophosphamide